Major Pharma Companies Harness Apheris for AI Drug Discovery
Discover how major pharmaceutical companies are using the Apheris Compute Gateway to revolutionize AI-driven drug discovery and accelerate innovation.
Topic
Apheris
A collection of 4 issues
Apheris Secures $8.25M in Series A for Life Sciences Computing
Apheris, a leader in federated computing within life sciences, secures $8.25 million in Series A funding. Explore their innovative approach to data-driven solutions.
Apheris Gains Momentum with Pharma Pivot in 2023
Apheris's 2023 pivot to pharma and life sciences sparks a fourfold revenue surge. Discover how this strategic shift is transforming the company.
Apheris Revolutionizes Life Sciences with Federated AI
Discover how Apheris tackles AI data challenges in life sciences through federated computing, ensuring secure data access without relocation.